Oceania Healthcare : Half Year Accounts

onlyIn the six months to 30 September

2021, Oceania has achieved a

20% growth in unaudited underlying

EBITDA compared to the prior

usecorresponding period, with a solid

performance across its sales and

personal

developments despite the ongoing

COVID-19 restrictions. The business

has responded well through high

levels of vaccination, regular

communications with staff, residents

and their families, as well as a

significant investment in surveillance.

r

01

This forms the basis of the trading highlights pages in the Interim Report.

only

Underlying earnings six month comparative position

Unaudited

Unaudited

6 months to

6 months to

$NZ000's

September 2021

September 2020

Care

10,991

9,135

Village operating

11,399

7,646

Resales cap gain

10,639

6,201

Development margin

15,252

16,782

Corporate1

(11,814)

(9,253)

use

Group U/L EBITDA

36,467

30,511

Interest

(3,900)

(3,622)

Depreciation

(5,059)

(4,351)

Underlying NPAT

27,508

22,538

C re Suite depreciation

(4,807)

(3,408)

Adjusted Underlying NPAT

22,701

19,130

Occupied beds per day

2,336

2,273

Effective bed capacity per day

2,526

2,495

Effective occupancy (%)

92.5%

91.1%

Existing ORAs sold

45

24

New ORAs sold

57

57

Existing Care Suites sold

84

62

New Care Suites sold

44

65

Total ORAs sold

230

208

1 On 21 April 2020 the Group claimed, and received payment of, a COVID-19 wage subsidy

totalling $1.8m. This amount has subsequently been repaid in full on 18 May 2021 and as a result

has been excluded from the table above. This proforma adjustment increases underlying EBITDA

and underlying NPAT in relation to the six month period to 30 September 2021 by $1.8m and

reduces the underlying EBITDA and underlying NPAT position in relation to the six month period

to 30 September 2020 by $1.8m.

personal

03

r